Wright, Shane C. http://orcid.org/0000-0002-7470-5068
Motso, Aikaterini
Koutsilieri, Stefania
Beusch, Christian M. http://orcid.org/0000-0001-9100-8283
Sabatier, Pierre http://orcid.org/0000-0002-2734-1791
Berghella, Alessandro http://orcid.org/0000-0002-1743-6404
Blondel-Tepaz, Élodie
Mangenot, Kimberley
Pittarokoilis, Ioannis http://orcid.org/0009-0008-1510-487X
Sismanoglou, Despoina-Christina
Le Gouill, Christian http://orcid.org/0000-0002-6455-1800
Olsen, Jesper V. http://orcid.org/0000-0002-4747-4938
Zubarev, Roman A. http://orcid.org/0000-0001-9839-2089
Lambert, Nevin A. http://orcid.org/0000-0001-7550-0921
Hauser, Alexander S. http://orcid.org/0000-0003-1098-6419
Bouvier, Michel http://orcid.org/0000-0003-1128-0100
Lauschke, Volker M. http://orcid.org/0000-0002-1140-6204
Funding for this research was provided by:
Svenska Sällskapet för Medicinsk Forskning (P18-0098; PD20-0153)
Alexander S. Onassis Public Benefit Foundation (F ZR 072-1/ 2021-2022)
Vetenskapsrådet (2022-00323)
Foundation for the National Institutes of Health (GM130142; GM145284)
Lundbeckfonden (R278-2018-180)
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-148431)
Article History
Received: 25 January 2023
Accepted: 19 September 2023
First Online: 9 October 2023
Competing interests
: M.B. is the president of the scientific advisory board for Domain Therapeutics. M.B. and C.L.G. have filed patent application (US20200256869A1) related to some of the biosensors used in this work and the technology has been licensed to Domain Therapeutics. All biosensors are available for academic research through regular material transfer agreement. V.M.L. is co-founder, the CEO, and shareholder of HepaPredict AB, as well as co-founder and shareholder of PersoMedix AB. A.M., S.K., P.S., C.M.B., A.B., E.B.-T., K.M., I.P., D-C.S., N.A.L., J.V.O., R.A.Z., A.S.H. and S.C.W. declare no competing interests.